4
- RESEARCH HIGHLIGHT
A study identifies gene variants that help explain why some people respond better to GLP-1 medications than others, paving the way for precision approaches to treating obesity.
A study identifies gene variants that help explain why some people respond better to GLP-1 medications than others, paving the way for precision approaches to treating obesity.
At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.
Contact (global@srivax.com)